Lymphoma, Follicular: all 964 studies
Page 1 of 10. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- Ceritinib Treatment for Recurrent MeningiomasNot yet recruitingNCT07893197Phase 2
- IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade AstrocytomasNot yet recruitingNCT07888647Phase 2
- Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.Not yet recruitingNCT07883941Phase 1
- Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell TherapyNot yet recruitingNCT07875413Phase 2
- Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer PatientsNot yet recruitingNCT07869797
- A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic ImpairmentNot yet recruitingNCT07853040Phase 1
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506RecruitingNCT07844967Phase 1
- PMCF Study Fortilink-TC TiRecruitingNCT07834931
- PMCF Study Fortilink-TS TiRecruitingNCT07834736
- Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and OlderNot yet recruitingNCT07828730Not applicable
- Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphomaNot yet recruitingNCT07783594Phase 2
- TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following HospitalizationEnrolling by invitationNCT07780097Not applicable
- Low-Sodium Diet for Postpartum Blood Pressure ControlNot yet recruitingNCT07752056Not applicable
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)RecruitingNCT07750886
- A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular LymphomaNot yet recruitingNCT07736950Phase 3
- Tafasitamab and Rituximab for the Treatment of Newly Diagnosed Follicular LymphomaRecruitingNCT07731789Phase 2
- A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular LymphomaNot yet recruitingNCT07719855Phase 3
- A Study of ARC-02 in B-cell NHLRecruitingNCT07691606Phase 1
- Tirzepatide in the Treatment of Cannabis Use DisorderNot yet recruitingNCT07671248Phase 3
- Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot StudyNot yet recruitingNCT07664787Not applicable
- Axatilimab + CAR-T for High-Risk LymphomaNot yet recruitingNCT07638982Phase 1
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)RecruitingNCT07634471Phase 2/3
- Buprenorphine Implementation at Syringe Service Programs to Reduce OverdosesRecruitingNCT07631598Not applicable
- A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.RecruitingNCT07630545Phase 1
- A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell MalignanciesRecruitingNCT07609862Phase 1/2
- Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell LymphomaNot yet recruitingNCT07609446
- Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK InhibitorsNot yet recruitingNCT07592481Not applicable
- A Exploratory Study on Untreated Follicular Lymphoma With Orelabrutinib, Tafasitamab, and LenalidomideNot yet recruitingNCT07585747Phase 2
- A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular LymphomaRecruitingNCT07562022Phase 3
- A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic ImpairmentRecruitingNCT07559474Phase 1
- A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress SyndromeRecruitingNCT07558538Early Phase 1
- Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular LymphomaRecruitingNCT07555470Phase 2
- Sonrotoclax, Zanubrutinib and Rituximab in Previously Untreated Patients With Follicular LymphomaNot yet recruitingNCT07550855Phase 2
- Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic ImpairmentNot yet recruitingNCT07550634Phase 1
- A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin LymphomaRecruitingNCT07548697Early Phase 1
- A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234RecruitingNCT07546760Phase 1
- Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular LymphomaRecruitingNCT07545603Phase 2
- Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant VolumeRecruitingNCT07528781
- A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)RecruitingNCT07519772Phase 1/2
- ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular LymphomaNot yet recruitingNCT07505849Phase 2
- NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)RecruitingNCT07502118Phase 2/3
- Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDSRecruitingNCT07490925Not applicable
- A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell MalignanciesNot yet recruitingNCT07476378Not applicable
- Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasRecruitingNCT07468136Phase 1/2
- Family-Focused Study to Support Medication for Opioid Use DisorderNot yet recruitingNCT07451197Not applicable
- A Study of APG-3288 in Relapsed/Refractory Blood CancersRecruitingNCT07424833Phase 1
- Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic ImpairmentRecruitingNCT07422610Phase 1
- Reduced Dosage and/or Visitation Protocol for the Treatment of Acute Malnutrition in KenyaNot yet recruitingNCT07420062Not applicable
- Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular LymphomaRecruitingNCT07418190Phase 2
- This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including RNot yet recruitingNCT07412405Not applicable
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin CombinationNot yet recruitingNCT07410052Not applicable
- Efficacy and Safety of TC011 in Relapsed or Refractory Follicular LymphomaNot yet recruitingNCT07360288Phase 2
- IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular LymphomaNot yet recruitingNCT07355283Phase 3
- Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput SequencingEnrolling by invitationNCT07345377Not applicable
- huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular LymphomaRecruitingNCT07343934Phase 1
- Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress SyndromeNot yet recruitingNCT07334873Not applicable
- Remission in Adults With Severe Asthma in ThailandRecruitingNCT07328035
- Zanubrutinib, Obinutuzumab Combined With Lenalidomide (ZGR) for the Treatment of Untreated Follicular LymphomaRecruitingNCT07299149Phase 2
- Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).RecruitingNCT07278921
- PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)RecruitingNCT07263490
- Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in ItalyRecruitingNCT07256015
- Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of LymphomaRecruitingNCT07249905Phase 1/2
- A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersRecruitingNCT07226843Phase 1
- Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)RecruitingNCT07225439Phase 1
- Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerRecruitingNCT07215910Phase 3
- Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving SurgeryRecruitingNCT07206121Not applicable
- PEEP-induced Effects on Respiratory dRivE and EFfortRecruitingNCT07203781Not applicable
- Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)RecruitingNCT07197307Phase 2
- Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .RecruitingNCT07191249Phase 2
- Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe AsthmaRecruitingNCT07189806
- Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular LymphomaNot yet recruitingNCT07187960Phase 3
- EGPSS for Weight Management in an in Vivo Human ModelEnrolling by invitationNCT07186959Not applicable
- The PRE-VAIL StudyRecruitingNCT07176624Not applicable
- Watch and Wait or Worry and Wait in Indolent LymphomaEnrolling by invitationNCT07173790
- CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell LymphomasEnrolling by invitationNCT07168486Phase 1
- Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell LymphomaNot yet recruitingNCT07168291Early Phase 1
- Optimizing Preeclampsia Postpartum With Point-of-care UltrasoundNot yet recruitingNCT07167862Phase 4
- A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic MalignanciesRecruitingNCT07154823
- Odronextamab in Low Tumor Volume Advanced FLRecruitingNCT07128641Phase 2
- Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular LymphomaRecruitingNCT07126678Not applicable
- This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin LymphomaRecruitingNCT07121946Phase 1
- FTT PET/CT in Pancreatic Neuroendocrine TumorsRecruitingNCT07114939Phase 1
- Evaluating Near-infrared Spectroscopy Devices for Monitoring Traumatic Brain InjuryNot yet recruitingNCT07106216
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )RecruitingNCT07101328Phase 1
- PGx Medication Safety Reviews of Persons With IDDNot yet recruitingNCT07092852
- Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)RecruitingNCT07083154Phase 3
- Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell LymphomaRecruitingNCT07077512Phase 2
- A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FLNot yet recruitingNCT07031700Phase 2
- Swedish Cardiac And Renal Failure Study-1RecruitingNCT07029503Phase 2
- A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasRecruitingNCT07029217Phase 3
- ASV Therapy for InsomniaRecruitingNCT07011966Not applicable
- Long-term Study to Evaluate Safety and Persistence of GF-CART01Enrolling by invitationNCT06985576
- Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesRecruitingNCT06980116Phase 1
- Evaluation of Skin Tests in Biotherapy AllergiesRecruitingNCT06971848Not applicable
- Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3ANot yet recruitingNCT06961500Phase 2
- Zanubrutinib Combined With G-CVP in Previously Untreated FLRecruitingNCT06959732Phase 2
- Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL TrialRecruitingNCT06948786Phase 2
- Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma SurgeryRecruitingNCT06941194Not applicable
- Cognitive Screening Made Easy for PCPs - Administrative SupplementRecruitingNCT06928298Not applicable